banner
Lactate dehydrogenase A (LDHA) inhibitor, GNE-140 racemic, Purity ≥98%

Cat. No.: X24-09-YM579

Lactate dehydrogenase A (LDHA) inhibitor, GNE-140 racemic, Purity ≥98%

Synonym: 1809794-70-4; 3-((2-Chlorophenyl)thio)-4-hydroxy-6-(4-morpholinophenyl)-6-(thiophen-3-yl)-5,6-dihydropyridin-2(1H)-one; 5-(2-Chlorophenyl)sulfanyl-4-hydroxy-2-(4-morpholin-4-ylphenyl)-2-thiophen-3-yl-1,3-dihydropyridin-6-one; Lactate dehydrogenase A (LDHA) inhibitor

  • CAS Number: 1809794-70-4
  • Compound CID: 118384502
Product Size
1 g; 2 g; 5 g; 10 g
Price
Datasheet
MSDS
Properties
Description
GNE-140 racemic is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lactate dehydrogenase A (LDHA). The molecular weight of the compound is 499.04, and its molecular formula is C25H23ClN2O3S2.
Molecular Weight
499.04
Molecular Formula
C25H23ClN2O3S2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
GNE-140 racemic can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes by enhancing insulin sensitivity and regulating glucose levels.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

  • SUITE 201, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-637-6119
Copyright © 2025 CD BioGlyco. All rights reserved.
0
There is no product in your cart.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x